A. Mladovan

发表

Three novel hormone‐responsive cell lines derived from primary human breast carcinomas: Functional characterization

I. Lüthy, A. Baldi, S. M. Vázquez, 2004, Journal of cellular physiology.

Human breast cell lines exhibit functional α2-adrenoceptors

A. Bruzzone, I. Lüthy, A. Baldi, 2006, Cancer Chemotherapy and Pharmacology.

Increment of DNA topoisomerases in chemically and virally transformed cells.

M. Crespi, A. Baldi, A. Mladovan, 1988, Experimental cell research.

Histamine modulates the expression of c-fos through cyclic AMP production via the H2 receptor in the human promonocytic cell line U937.

C. Shayo, C. Davio, A. Baldi, 1997, Molecular pharmacology.

Histamine H2 receptor desensitization: involvement of a select array of G protein-coupled receptor kinases.

C. Shayo, C. Davio, F. Monczor, 2001, Molecular pharmacology.

Expression of histamine receptors in different cell lines derived from mammary gland and human breast carcinomas

C. Davio, A. Baldi, G. Cricco, 1995, Inflammation Research.

Histamine H2 receptor overexpression induces U937 cell differentiation despite triggered mechanisms to attenuate cAMP signalling.

C. Shayo, C. Davio, F. Monczor, 2006, Biochemical pharmacology.

Differentiating agents modulate topoisomerase I activity in U-937 promonocytic cells.

C. Shayo, A. Baldi, A. Mladovan, 1997, European journal of pharmacology.

Angiotensin II phosphorylation of extracellular signal-regulated kinases in rat anterior pituitary cells.

D. Becu-Villalobos, A. Baldi, G. Díaz-Torga, 2003, American journal of physiology. Endocrinology and metabolism.

Histamine receptors in neoplastic transformation: Studies in human cell lines

C. Shayo, C. Davio, A. Baldi, 1996, Inflammation Research.

H1 and H2 histamine receptors mediate the production of inositol phosphates but not cAMP in human breast epithelial cells

C. Shayo, C. Davio, F. Monczor, 2002, Inflammation Research.

Human breast cell lines exhibit functional alpha2-adrenoceptors.

A. Bruzzone, I. Lüthy, A. Baldi, 2006, Cancer chemotherapy and pharmacology.